Consistent with the findings that intestinal AMPK, which mediates NAMPT activation, is impaired in glucose intolerance, HFD-induced obesity, and aging downregulates the major NAD+-generating enzymes, including NAMPT, and reduces intestinal NAD+ levels [31,99,100]. This evidence concerns the gene NAMPT and obesity due to melanocortin 4 receptor deficiency.